What is CERO's health score?

CERO THERAPEUTICS HOLDINGS, INC. (CERO) has a TradeApes health score of 42 out of 100, rated Weak. This composite score evaluates financial strength, operating trends, valuation, capital allocation, and risk factors.

What is CERO's estimated fair value?

Based on our 5-year discounted cash flow model, CERO THERAPEUTICS HOLDINGS, INC.'s estimated fair value is $N/A per share. This is a model estimate, not a price target or investment recommendation.

Is CERO undervalued or overvalued?

Our model currently rates CERO as Inconclusive. This assessment combines health metrics, valuation multiples, and market sentiment. Individual investors should conduct their own due diligence.

Crunching the numbers for CERO... Refresh in a moment for the full analysis.

CERO THERAPEUTICS HOLDINGS, INC. (CERO)

Healthcare Inconclusive inconclusive weak

$0.01

Updated: 2026-06-05

TradeApes Score

Financial Strength

40 Weak

Operating Trend

50 Mixed

Relative Value

15 Stressed

Capital Allocation

50 Mixed

Risk

80 Strong

Key Findings

− Historically expensive — EV/EBITDA in top 20% of its 5-year range

Unlock Full Report →

1 free score card remaining

TradeApes provides financial data, analytics, and research tools. TradeApes is not a registered investment adviser, broker-dealer, or tax advisor. The information presented is for educational and informational purposes only and does not constitute investment, financial, or tax advice.

11 sector-leading stocks delivered to your inbox every Sunday. Free.

No spam. Unsubscribe anytime.